This ETF's Trouncing the S&P 500 by 10 Percentage Points in 2026, and It Can Keep Outperforming

The real edge here is not “dividends” but factor purity: the basket concentrates on businesses with self-funding balance sheets and visible cash conversion, which makes it behave more like a quality/capital-allocation ETF than a classic value sleeve. In this regime, the market is paying for duration in cash flows and punishing capex-heavy growth, so names tied to energy infrastructure, healthcare cash generation, and defensive staples should continue to win on relative revisions even if the broad market flatlines.

The second-order beneficiary is the supplier ecosystem around AI and reindustrialization, not the hyperscalers themselves. If AI capex stays elevated, the incremental spend flows into power, equipment, and midstream/logistics rather than into the software complex; that creates a multi-quarter tailwind for the highest-cash-flow producers in CVX/COP and for industrial input providers indirectly, while leaving growth valuation leadership structurally challenged.

The biggest risk to the trade is not a macro slowdown, but a rapid rotation back into mega-cap growth if rates fall faster than expected or AI spending becomes more monetizable than feared. In that case, the “quality value” premium compresses quickly because these stocks have already rerated on defensive ownership; the ETF can underperform for weeks at a time if the market starts rewarding long-duration earnings again. The contrarian point is that the valuation gap is wide, but not all cheap is mispriced: some of these names are cheap because their growth is genuinely low, so sustained outperformance likely depends on continued capital-return discipline and stable policy rather than multiple expansion alone.